Andmed seisuga: 24.11.2024 19:36 (GMT+2)
TALLINNA FARMAATSIATEHAS
INCOME STATEMENT
CONSOLIDATED INCOME STATEMENT 01.01-31.12.99
Consolidated, unaudited, in thousand EEK
Consolidated Parent
31.12.1999 31.12.1998 31.12.1999 31.12.1998
REVENUE
NET SALES 74811 83613 74811 83588
CHANGE IN INVENTORIES -2385 -4164 -2385 -4158
OTHER REVENUE 6365 234 6365 226
TOTAL REVENUE 78791 79683 78791 79657
EXPENSES
MATERIALS, CONSUMABLES AND SUPPLIES -31103 -42790 -31103 -42737
OTHER OPERATING EXPENSES -11752 -58509 -11752 -58276
PERSONNEL EXPENSES -16320 -22573 -16320 -21865
DEPRECIATION -5885 -9384 -5885 -9215
OTHER EXPENSES -4802 -27078 -4802 -27077
TOTAL EXPENSES -70053 -160334 -70053 -159170
OPERATING PROFIT (-LOSS) 8927 -80651 8927 -79513
INCOME/COST OF EQUITY HOLDING 3561 339 3561 339
OTHER FINANCIAL INCOME 190 816 190 575
AMORTIZATION OF GOODWILL -1513 -6136 -1513 -6136
OTHER FINANCIAL EXPENSES -5315 -10648 -5315 -11538
TOTAL -3077 -15629 -3077 -16760
PROFIT (-LOSS) BEFORE
INCOME TAX 5850 -96280 5850 -96273
INCOME TAX 3454 3454
Incl. DEFERRED INCOME TAX
PROFIT AFTER INCOME TAX -92826 -92819
NET PROFIT (-LOSS) FOR Q2
Earnings per share
Raivo Unt
Financial director
6120201